Advertisement

Moricizine (ethmozine HCl) — A new antiarrhythmic drug: Is it unique

  • Philip J. Podrid
    Correspondence
    Address for reprints: Philip J. Podrid, MD, Section of Cardiology, Boston University School of Medicine, University Hospital, Boston, Massachusetts 02118.
    Affiliations
    From the Section of Cardiology, Boston University School of Medicine, University Hospital, Boston, Massachusetts USA
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.

      References

        • Bigger JT
        Cardiac electrophysiologic effects of moricizine hydrochloride.
        Am J Cardiol. 1990; 65: 15D-20D
        • Makielski JC
        • Undrovinas AI
        • Hanck DA
        • Sheets MF
        • Nesterenko VV
        • Alpert LA
        • Rosenshtraukh LV
        • Fozzard HA
        Use dependent block of sodium currents by ethmozine in voltage clamped internally perfused canine cardiac Purkinje cells.
        J Mol Cell Cardiol. 1988; 20: 255-265
        • Arnsdorf MF
        • Sawicki GJ
        Effects of ethmozine on excitability in sheep Purkinje fibers: the balance among active and passive cellular properties which comprise the electro-physiologic matrix.
        J Pharmacol Exp Ther. 1989; 248: 1158-1166
        • Dremen SA
        • Aniukhovskii EP
        • Rosenshtraukh LV
        • Hageman GR
        • Urtaler F
        Action of ethmozine on normal and anomalous forms of Purkinje fiber automaticity in the dog.
        Kardiologia. 1986; 26: 10-15
        • Dangman KH
        • Hoffman BF
        Antiarrhythmic effects of ethmozine in cardiac Purkinje fibers: suppression of automaticity and abolition of triggering.
        J Pharmacol Exp Ther. 1983; 227: 578-586
        • Wyndham CRC
        • Pratt CM
        • Mann DE
        • Winkle RA
        • Somberg J
        • DeMaria AN
        • Josephson ME
        Electrophysiology of ethmozine (moricizine HCL) for ventricular tachycardia.
        Am J Cardiol. 1987; 60: 67F-72F
        • Morganroth J
        Dose efficacy of moricizine on suppression of ventricular arrhythmias.
        Am J Cardiol. 1990; 65: 26D-31D
        • Siddoway LA
        • Schwartz SL
        • Barbey JT
        • Woosley RL
        Clinical pharmacokinetics of moricizine.
        Am J Cardiol. 1990; 65: 21D-25D
        • Biollaz J
        • Shaheen O
        • Wood AJJ
        Cimetidine inhibition of ethmozine metabolism.
        Clin Pharmacol Ther. 1985; 37: 665-668
        • Kennedy HL
        • Sprague MK
        • Redd RM
        • Wiens RD
        • Blum RI
        • Buckingham TA
        Serum digoxin concentrations during ethmozine therapy.
        Am Heart J. 1986; 111: 667-672
        • Pratt CM
        • Podrid PJ
        • Seals AA
        • Young JB
        • Hession M
        • Lampert S
        • Quinones M
        • Lown B
        Effects of ethmozine (moricizine HCL) in ventricular function using echocardiographic, hemodynamic and radionuclide assessments.
        Am J Cardiol. 1987; 60: 73F-77F
        • Podrid PJ
        • Lyakishev A
        • Lown B
        • Mazur N
        Ethmozine, a new antiarrhythmic drug for suppressing ventricular premature complexes.
        Circulation. 1980; 61: 450-457
        • Pratt CM
        • Yepsen SC
        • Taylor AA
        • Mason PT
        • Miller RR
        • Quinone MA
        • Lewis RA
        Ethmozine suppression of single and repetitive ventricular premature depolarization during therapy: documentation of efficacy and long-term safety.
        Am Heart J. 1983; 106: 85-91
        • Morganroth J
        • Pratt CM
        • Kennedy HL
        • Singh SN
        • Blatt ML
        • Baker BJ
        • Mason DT
        Efficacy and tolerance of ethmozine (moricizine HCl) in placebo controlled trials.
        Am J Cardiol. 1987; 60: 48F-51F
        • The Cardiac Arrhythmia Pilot Study Investigators
        Effect of encainide, flecainide, inipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS.
        Am J Cardiol. 1988; 61: 501-509
        • Cardiac Arrhythmia Suppression Trial (CAST) Investigators
        Preliminary Report. Effects of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression of the myocardial infarction.
        N Engl J Med. 1989; 321: 406-411
        • Anderson JL
        Comparison of efficacy and tolerance of moricizine with other antiarrhythmic agents in the treatment of chronic ventricular arrhythmias.
        Am J Cardiol. 1990; 65: 32D-40D
        • Hession MJ
        • Lampert S
        • Podrid PJ
        • Lown B
        Ethmozine (moricizine HCl) therapy for complex ventricular arrhythmias.
        Am J Cardiol. 1987; 60: 59F-66F
        • Horowitz LN
        Efficacy of moricizine in malignant ventricular arrhythmias.
        Am J Cardiol. 1990; 65: 41D-46D
        • Evans VL
        • Garson A
        • Smith RT
        • Moak JP
        • McVey P
        • McNamara DG
        Ethmozine (moricizine HCl): a promising drug for “automatic” atrial ectopic tachycardia.
        Am J Cardiol. 1987; 60: 83F-86F
        • Chazov EF
        • Shugushev KK
        • Rosenshraukh LV
        Ethmozine I. Effects of intravenous drug administration on paroxysmal supraventricular tachycardia in the ventricular preexcitation syndrome.
        Am Heart J. 1984; 108: 475-482
        • Chazov EF
        • Rosenshtraukh LV
        • Shugushev KK
        Ethmozine II. Effects of intravenous drug administration on atrioventricular nodal reentrant tachycardia.
        Am Heart J. 1984; 108: 483-489
        • Kennedy HL
        Noncardiac adverse effects and organ toxicity of moricizine during short and long term studies.
        Am J Cardiol. 1990; 60: 47D-50D
        • Podrid PJ
        • Lampert S
        • Graboys TB
        • Blatt CM
        • Lown B
        Aggravation of arrhythmia by antiarrhythmic drugs. Incidence and predictors.
        Am J Cardiol. 1987; 59: 38E-44E
        • Pratt C
        • Podrid PJ
        • Greatrix B
        • Borland MR
        • Mahler S
        Efficacy and safety of moricizine in congestive heart failure: experience in the United States.
        Am Heart J. 1989; 119: 1-7
        • Ravid S
        • Podrid PJ
        • Lampert S
        • Lown B
        Congestive heart failure induced by six of the new antiarrhythmic drugs.
        J Am Coll Cardiol. 1989; 14: 1326-1330